Sort
39,280 grants matching “leukemia”
Modeling myelodysplasia
$578,295H Leighton Grimes · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · CA
Targeting TET DNA Dioxygenases as Therapeutic Principle in Myeloid Neoplasms
$577,908Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · CA
NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN)
$577,848Elaine R Mardis · Washington University · U01 · FY2011 · GM
Hyperglycemia mediated myeloproliferative disease
$577,831Reuben Kapur · Indiana University Indianapolis · R01 · FY2020 · HL
The role for phase separation in oncogenesis and aberrant chromatin looping formation
$577,786G Greg Wang · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
The role for phase separation in oncogenesis and aberrant chromatin looping formation
$577,785G Greg Wang · Duke University · R01 · FY2025 · CA
Botswana Birth Outcomes Surveillance Extension
$577,763Roger L Shapiro · Harvard School Of Public Health · R01 · FY2022 · HD
Role of an Integrator-EGR axis in the regulation of myeloid enhancers
$577,605Alessandro Gardini · Wistar Institute · R01 · FY2021 · HL
Defining the scope and clinical impact of donor CHIP after allogeneic HCT
$577,528Robert Coleman Lindsley · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Defining the Role of Alternative Polyadenylation in Macrophage Differentiation and Function
$577,311Claire L Moore · Tufts University Boston · R01 · FY2020 · AI
Modeling myelodysplasia
$577,146H Leighton Grimes · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · CA
VCU Minority-Based CCOP
$577,110John D Roberts · Virginia Commonwealth University · U10 · FY2008 · CA
Heartland Cancer Research CCOP
$577,095Alan P Lyss · Missouri Baptist Medical Center · U10 · FY2012 · CA
MIRNA-MEDIATED RESCUE OF NK CELL CYTOTOXICITY AGAINST DRUG-RESISTANT QUIESCENT LEUKEMIA STEM CELLS
$577,082University Of Maryland, Baltimore · · FY2019 · Defense Health Agency
Processed Antigen Characterization by Mass Spectrometry
$577,016Donald F Hunt · University Of Virginia · R01 · FY2010 · AI
Signal Transduction by Tyrosine Phosphorylation
$577,006Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2015 · CA
NMR Studies of Retroviral Nucleic Acid Binding Proteins
$576,864Michael F. Summers · University Of Maryland Baltimore County · R01 · FY2013 · GM
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)
$576,724William E. Evans · St. Jude Children'S Research Hospital · R37 · FY2008 · CA
Antigenic basis of immune responses after immune modulatory therapies post-HCT
$576,722Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2019 · CA
Antigenic basis of immune responses after immune modulatory therapies post-HCT
$576,722Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Antigenic basis of immune responses after immune modulatory therapies post-HCT
$576,722Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2021 · CA
Defining the scope and clinical impact of donor CHIP after allogeneic HCT
$576,720Robert Coleman Lindsley · Dana-Farber Cancer Inst · P01 · FY2021 · CA
Instructive role of MLL fusion proteins in lineage determination and leukemogenesis
$576,709Michael J Thirman · University Of Chicago · R01 · FY2019 · CA
Mechanisms of Murine Turmor Eradication by Immunotherapy
$576,505Philip D Greenberg · University Of Washington · R01 · FY2016 · CA
Stanford University NCTN- Network Lead Academic Site
$576,471Heather Ann Wakelee · Stanford University · U10 · FY2014 · CA